Fungal infections: current diagnosis and treatment

被引：5

作者：

Cordonnier, C ^{[1
]}

机构：

[1] Hop Henri Mondor, F-94010 Creteil, France

来源：

HEMATOLOGY JOURNAL | 2004年 / 5卷

关键词：

D O I：

10.1038/sj.thj.6200424

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S59 / S62

页数：4

共 13 条

[1] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].

Ascioglu, S ;

Rex, JH ;

de Pauw, B ;

Bennett, JE ;

Bille, J ;

Crokaert, F ;

Denning, DW ;

Donnelly, JP ;

Edwards, JE ;

Erjavec, Z ;

Fiere, D ;

Lortholary, O ;

Maertens, J ;

Meis, JF ;

Patterson, TF ;

Ritter, J ;

Selleslag, D ;

Shah, PM ;

Stevens, DA ;

Walsh, TJ .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14

[2] Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model [J].

Becker, MJ ;

de Marie, S ;

Willemse, D ;

Verbrugh, HA ;

Bakker-Woudenberg, IAJM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1434-1438

[3] Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients [J].

Bretagne, S ;

MarmoratKhuong, A ;

Kuentz, M ;

Latge, JP ;

BartDelabesse, E ;

Cordonnier, C .

JOURNAL OF INFECTION, 1997, 35 (01) :7-15

[4] Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies [J].

Cornely, OA ;

Ullmann, AJ ;

Karthaus, M .

BLOOD, 2003, 101 (09) :3365-3372

[5] Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis [J].

Costa, C ;

Costa, JM ;

Desterke, C ;

Botterel, F ;

Cordonnier, C ;

Bretagne, S .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2224-2227

[6] Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening [J].

Hebart, H ;

Löffler, J ;

Meisner, C ;

Serey, F ;

Schmidt, D ;

Böhme, A ;

Martin, H ;

Engel, A ;

Bunjes, D ;

Kern, WV ;

Schumacher, U ;

Kanz, L ;

Einsele, H .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1713-1719

[7] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[8] Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation [J].

Maertens, J ;

Verhaegen, J ;

Lagrou, K ;

Van Eldere, J ;

Boogaerts, M .

BLOOD, 2001, 97 (06) :1604-1610

[9] Ltraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants [J].

Marr, KA ;

Crippa, F ;

Leisenring, W ;

Hoyle, M ;

Boeckh, M ;

Balajee, SA ;

Nichols, WG ;

Musher, B ;

Corey, L .

BLOOD, 2004, 103 (04) :1527-1533

[10] Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients [J].

Marr, KA ;

Carter, RA ;

Crippa, F ;

Wald, A ;

Corey, L .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :909-917

← 1 2 →